查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1947980

全球机器人静脉输液配製系统市场（按最终用户、应用、系统类型和组件划分）预测（2026-2032）

Robotic IV Compounding System Market by End User, Application, System Type, Component - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年机器人静脉输液系统市值为 3.1753 亿美元，预计到 2026 年将成长至 3.4527 亿美元，预计到 2032 年将达到 5.9957 亿美元，复合年增长率为 9.50%。

关键市场统计数据
基准年 2025 3.1753亿美元
预计年份：2026年 3.4527亿美元
预测年份 2032 5.9957亿美元
复合年增长率 (%) 9.50%

简要介绍机器人静脉输液系统在现代医疗保健服务中的作用

自动化和机器人技术的进步正在重塑复杂静脉输液疗法的配製方式，机器人静脉输液配药系统正成为药房服务安全性、准确性和营运稳定性的核心驱动力。这些系统将机械精度与软体控制相结合，以减少人为错误、提高配药的重复性并规范无菌操作技术。随着肿瘤学、肠外营养和镇痛治疗等领域临床需求的不断增长，医疗机构不仅从合规性和安全性的角度评估自动化，而且将其视为产能规划和人员优化的一种手段。

变革性变化正在重塑临床环境中机器人静脉输液系统的实施和效能预期。

多种因素正在重塑机器人静脉输液系统的市场格局，这些因素影响系统的普及速度和性能预期。首先，医疗系统将用药安全和减少错误列为优先事项，这为以机械化、检验的工作流程取代人工输液方式提供了切实的动力。同时，机器人技术和视觉系统的进步提高了组件的可靠性，并实现了对剂量精度的更精确控制，从而提高了人们对自动化系统必须达到的标准。

评估2025年美国关税变化对机器人静脉输液系统相关人员的累积营运和采购影响

美国近期关税调整为采购计划、供应商选择以及诸如机器人静脉输液系统等资本设备的总体拥有成本评估带来了新的变数。关税变化不仅影响从海外进口的硬体组件（例如机械臂、视觉系统和专用感测器）的初始购置成本，还会影响备件定价和售后服务的经济效益。这些变更迫使采购团队重新评估供应商布局，考虑在地采购策略，并更深入评估供应商支援网路。

从深入的细分观点揭示了机器人静脉输液系统的最终用户、应用、系统类型和组件生态系统的不同采用趋势。

终端使用者的需求差异巨大：门诊手术中心优先考虑的是容量和快速响应；癌症中心面临着大量复杂的化疗通讯协定，需要严格的剂量控制和检验；医院需要能够适应不同复杂程度的学术和社区医疗机构的解决方案；零售药店需要在零售容量和配药安全之间取得平衡；而专科药店则专注于高度客製化的专科服务以及对专业操作的专业配药。这些不同的优先事项影响采购标准和对供应商支援模式的预期。

区域层面深入分析机器人静脉输液系统的关键应用驱动因素、监管影响和营运重点。

在美洲，医疗服务提供者优先考虑合规性、提高报销效率以及与医院资讯系统的集成，许多机构优先选择能够支援严格文件记录和互通性的解决方案。医疗机构通常优先考虑供应商服务网络和响应迅速的本地支持，以确保无菌用品的持续供应。跨境贸易政策和供应链因素也会影响筹资策略，各机构都在寻求进口零件和本地服务能力之间的平衡。

从企业层面竞争考察，揭示供应商能力、服务模式和伙伴关係策略如何塑造机器人静脉输液生态系统。

供应商透过硬体创新、软体整合能力以及深厚的服务和验证体系来脱颖而出。市场领导通常提供成熟的硬体产品组合，包括经过验证的机械臂、视觉系统和称重组件，以及支援审核、电子批次记录和与药房资讯系统连接的软体。此外，他们还提供全面的验证服务、培训计划和强大的售后支持，从而降低机构在实施和持续营运过程中的风险。

业界领导者可应用以下实用建议，以加速安全、永续且经济高效的机器人静脉输液系统的普及应用。

首先，要让临床、药房和采购部门的相关人员围绕通用目标达成一致，该目标优先考虑患者安全、工作流程效率和长期营运韧性。早期跨部门协作可以减少供应商评估过程中的误解，并有助于更顺畅的验证和实施流程。接下来，进行能力映射，以确定需要优先自动化的药房应用，例如化疗、经肠营养和大容量镇痛药配製，并确定是采用整合平台还是专用的独立系统。

我们对调查方法、资料来源和检验方法进行了透明的解释，以得出有关机器人静脉输液系统的可操作见解。

本研究整合了来自一手定性研究、二手文献、产品技术文件以及对临床负责人、药房主任、采购负责人和供应商负责人的结构化访谈的发现。一手研究包括深入讨论，旨在了解实际应用中的挑战、服务模式预期以及监管合规要求。二手资讯包括与无菌配製和医疗设备互通性相关的监管指导文件和广泛认可的技术标准。

针对机器人静脉输液系统的临床安全性、营运弹性和策略采购影响，总结简洁扼要的结论

机器人静脉输液系统被视为提升用药安全性、提高流程一致性并解决药局人员短缺问题的变革性工具。其应用需要采取综合方法，将临床需求与筹资策略和长期服务协议结合。相关人员可以透过决策来最大限度地发挥其优势，这些决策应考虑特定应用的需求、整合式和独立式系统结构之间的差异，以及可靠的检验和培训资源的可用性。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依最终用户分類的机器人静脉输液配製系统市场

  • 门诊手术中心
  • 癌症中心
  • 医院
    • 大学医院
    • 社区医院
  • 零售药房
  • 专科药房

9. 依应用分類的机器人静脉输液配製系统市场

  • 缓解疼痛
  • 化疗
  • 肠外营养

第十章 机器人静脉输液配药系统市场（依系统类型划分）

  • 整合药房自动化系统
  • 独立系统

11. 机器人静脉输液配製系统市场（依组件划分）

  • 硬体
    • 条码扫描器
    • 重力尺度
    • 机械臂
    • 视觉系统
  • 服务
  • 软体

12. 各区域机器人静脉输液配製系统市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 机器人静脉输液配製系统市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国机器人静脉输液配药系统市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

15. 美国机器人静脉输液配製系统市场

第十六章：中国机器人静脉输液配药系统市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AmerisourceBergen Corporation
  • ARxIUM Inc.
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Cerner Corporation
  • Fagron Sterile Services
  • ForHealth Technologies
  • Fresenius Kabi AG
  • Integrated Pharmacy Systems, LLC
  • Intelligen, Inc.
  • Kirby Lester LLC
  • KUKA AG
  • MedAvail Technologies, Inc.
  • Omnicell, Inc.
  • QFix GmbH
  • ScriptPro LLC
Product Code: MRR-4F7A6D4FB6BE

The Robotic IV Compounding System Market was valued at USD 317.53 million in 2025 and is projected to grow to USD 345.27 million in 2026, with a CAGR of 9.50%, reaching USD 599.57 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 317.53 million
Estimated Year [2026] USD 345.27 million
Forecast Year [2032] USD 599.57 million
CAGR (%) 9.50%

A concise, contextual introduction to the role of robotic IV compounding systems in modern healthcare delivery

Advances in automation and robotics are reshaping how complex intravenous therapies are prepared, with robotic IV compounding systems emerging as core enablers of safety, precision, and operational resilience within pharmacy services. These systems integrate mechanical precision with software control to reduce human error, improve repeatability of preparations, and standardize aseptic techniques. As clinical demands grow in oncology, parenteral nutrition, and analgesia, institutions increasingly evaluate automation not only for compliance and safety but also as an instrument of capacity planning and workforce optimization.

The interplay of regulatory scrutiny, stringent aseptic processing expectations, and rising complexity of therapy regimens has elevated compounding reliability to a strategic priority. In response, hospitals and specialty pharmacies are exploring comprehensive solutions that pair hardware such as robot arms, vision systems, and gravimetric scales with software that enables traceability and integration into electronic medication administration records. Transitional considerations include workflow redesign, staff training, and alignment with pharmacy quality assurance frameworks to fully realize gains in safety and throughput.

Across clinical settings, decision-makers must weigh capital allocation, service and maintenance models, and interoperability with existing automation platforms. These considerations drive a careful evaluation of integrated pharmacy automation systems versus standalone units, each presenting distinct trade-offs in scalability, vendor lock-in, and customization. Ultimately, robotic IV compounding systems are positioned as pivotal investments that support enhanced clinical outcomes, operational continuity, and stronger alignment between pharmacy operations and broader institutional safety goals.

Transformative shifts reshaping adoption and performance expectations for robotic IV compounding systems across clinical environments

The landscape for robotic IV compounding systems is being reshaped by converging forces that affect adoption velocity and performance expectations. First, healthcare systems are prioritizing medication safety and error reduction, creating a practical impetus to replace manual compounding methods with mechanized, validated workflows. In tandem, advances in robotics and vision systems have improved component reliability and enabled more refined control over dosing accuracy, which in turn raises the baseline expectations for what automation should deliver.

Secondly, integration capabilities have progressed, enabling tighter connectivity between compounding systems and pharmacy information systems, thereby facilitating electronic documentation, audit trails, and more efficient reconciliation processes. This integration reduces administrative burden and strengthens compliance posture, while also supporting analytics-driven process improvements. Thirdly, service delivery models are evolving as vendors extend lifecycle support through remote diagnostics, predictive maintenance, and subscription-style service offerings that shift certain risks from buyers to suppliers.

Regulatory emphasis on sterile compounding practices and heightened scrutiny following high-profile incidents have further accelerated the transition toward automated solutions that offer reproducible aseptic environments and rigorous verification mechanisms. Finally, workforce dynamics, including shortages of trained compounding pharmacists and technicians, are driving organizations to consider automation as a strategic lever to maintain capacity and refocus skilled staff on clinical oversight and patient-centered activities. Taken together, these shifts are elevating expectations regarding system interoperability, validation support, and long-term service commitments.

Assessing the cumulative operational and procurement implications of United States tariff changes in 2025 for robotic IV compounding system stakeholders

Recent tariff adjustments in the United States have introduced new variables into procurement planning, supplier selection, and total cost of ownership assessments for capital equipment such as robotic IV compounding systems. Tariff changes affect not only the upfront acquisition cost of hardware components imported from overseas, including robot arms, vision systems, and specialized sensors, but also influence spare parts pricing and aftermarket service economics. These shifts compel purchasing teams to reassess supplier footprints, consider localized sourcing strategies, and evaluate vendor support networks more closely.

Consequently, stakeholders are examining supply chain resilience with heightened scrutiny. Organizations are prioritizing vendors with diversified manufacturing bases or strong domestic service infrastructures to mitigate potential tariff-driven price volatility. Contract negotiations increasingly incorporate clauses addressing tariff pass-through, lead time protections, and contingency plans for parts obsolescence. Procurement teams are also working more closely with clinical and finance leaders to model the operational trade-offs of selecting integrated automation platforms versus modular or standalone systems that may offer different exposure to imported components.

In addition, maintenance agreements and spare parts inventories are being re-evaluated to reduce vulnerability to cross-border cost fluctuations. Some institutions are allocating contingency budgets for aftermarket support or negotiating bundled service contracts to stabilize long-term cost commitments. These strategic responses reflect a broader emphasis on supply chain transparency, vendor accountability, and risk-sharing arrangements that maintain clinical continuity and protect capital investments against external tariff pressures.

Insightful segmentation perspectives that illuminate distinct adoption dynamics across end users, applications, system types, and component ecosystems for robotic IV compounding systems

End user dynamics vary widely: ambulatory surgical centers prioritize throughput and quick turnaround, cancer centers face high volumes of complex chemotherapy protocols that demand stringent dose control and verification, hospitals require scalable solutions across both academic medical centers and community hospitals with differing levels of operational sophistication, retail pharmacies balance retail throughput with compounding safety, and specialty pharmacies focus on highly customized preparations and adherence to specialized handling standards. These divergent priorities shape procurement criteria and expected vendor support models.

Application-driven differentiation is equally significant, as analgesia compounding requires fast, safe handling of frequently administered preparations with robust verification steps, chemotherapy compounding hinges on containment, cytotoxic handling protocols, and cross-contamination controls, while parenteral nutrition formulations demand precise volumetric and gravimetric control to ensure nutrient balance and patient safety. Each application imposes distinct validation, training, and environmental control requirements that influence system selection and process redesign.

System type decisions pivot on whether organizations choose integrated pharmacy automation systems that offer comprehensive ecosystem-level interoperability and centralized control versus standalone systems that can be deployed incrementally to address specific bottlenecks. Finally, the component-level landscape encompasses hardware, services, and software, with hardware elements such as barcode scanners, gravimetric scales, robot arms, and vision systems forming the physical backbone, services encompassing installation, validation, and lifecycle support, and software enabling workflow orchestration, traceability, and systems integration to complete a compliant compounding solution.

Regional insights that clarify adoption drivers, regulatory influences, and operational priorities across major global geographies for robotic IV compounding systems

In the Americas, healthcare providers emphasize regulatory compliance, reimbursement-driven efficiency, and integration with hospital information systems, prompting many institutions to prioritize solutions that support rigorous documentation and interoperability. Facilities often focus on vendor service networks and rapid on-site support to maintain continuous sterile production. Cross-border trade policies and supply chain considerations also inform procurement strategies, with organizations seeking balanced approaches between imported components and local service capabilities.

Within Europe, the Middle East & Africa region, regulatory frameworks and national standards vary considerably, which drives a preference for configurable systems that can meet diverse compliance requirements. In parts of Europe, stringent aseptic processing regulations and centralized procurement can favor larger integrated systems, while in certain markets in the Middle East and Africa, adoption is influenced by infrastructure readiness, local maintenance capacity, and capital availability. Vendors pursuing these markets often adapt service models and training programs to accommodate regional heterogeneity.

Asia-Pacific presents a mix of rapid adoption in advanced urban centers and emerging demand in markets building clinical infrastructure. Stakeholders in leading economies prioritize high-throughput automation and advanced analytics to support large-volume oncology and tertiary care settings, whereas other markets focus on scalable, cost-effective solutions that balance automation benefits with budgetary constraints. Across all regions, local training, validation capacity, and vendor aftercare remain central determinants of successful deployment and long-term operational sustainability.

Key competitive and collaborative company-level insights that reveal how vendor capabilities, service models, and partnership strategies shape the robotic IV compounding ecosystem

Vendors differentiate themselves through a combination of hardware innovation, software integration capabilities, and the depth of their service and validation offerings. Market leaders often bring mature hardware portfolios with proven robot arms, vision systems, and gravimetric components, coupled with software that supports audit trails, electronic batch records, and connectivity to pharmacy information systems. These capabilities are reinforced by comprehensive validation services, training programs, and robust aftermarket support that reduce institutional risk during deployment and ongoing operations.

Strategic partnerships between technology providers, system integrators, and clinical advisory bodies have become common, enabling faster implementation and more credible validation pathways. Some companies focus on modular solutions that allow phased adoption, while others emphasize fully integrated platforms designed for enterprise-wide standardization. Service differentiation is frequently expressed through advanced maintenance models, remote diagnostics, and tailored training curricula that shorten ramp-up times and improve system uptime.

Competitive dynamics also reflect a focus on interoperability, with vendors investing in open APIs and standardized communication protocols to reduce integration friction with existing pharmacy ecosystems. Additionally, companies that demonstrate strong regulatory support, including documentation and validation toolkits, tend to be preferred by institutions with high compliance expectations. Ultimately, procurement decisions hinge on a vendor's ability to deliver a balanced proposition of proven hardware, adaptable software, and predictable service delivery.

Actionable recommendations that industry leaders can apply to accelerate safe, sustainable, and cost-effective adoption of robotic IV compounding systems

Begin by aligning clinical, pharmacy, and procurement stakeholders around shared objectives that prioritize patient safety, workflow efficiency, and long-term operational resilience. Early cross-functional engagement reduces misalignment during vendor evaluation and facilitates a smoother validation and implementation process. Next, conduct a capability mapping exercise to identify which compounding applications-such as chemotherapy, parenteral nutrition, or high-volume analgesia-require prioritized automation, thereby informing whether to pursue integrated platforms or targeted standalone systems.

Prioritize vendors that demonstrate clear interoperability roadmaps and provide strong validation and training support. Evaluate service models not only for initial installation but for predictable lifecycle maintenance, remote diagnostic capabilities, and parts availability. To mitigate external supply chain and tariff-related risks, favor vendors with diversified manufacturing footprints or robust local service ecosystems. Additionally, incorporate structured change management programs that include competency-based training, documented standard operating procedures, and staged acceptance testing to ensure safe transition of compounding activities.

Finally, embed continuous improvement by establishing performance metrics tied to safety, throughput, and downtime, and leverage vendor partnerships to analyze data and optimize processes. These steps collectively reduce implementation risk, improve clinical outcomes, and create a foundation for scalable automation across pharmacy services.

A transparent explanation of research methodology, data sources, and validation practices used to generate actionable insights for robotic IV compounding systems

This research synthesizes insights from a combination of primary qualitative engagements, secondary public-domain literature, product technical documentation, and structured interviews with clinical leaders, pharmacy directors, procurement professionals, and vendor representatives. Primary engagements involved in-depth discussions to understand real-world deployment challenges, service model expectations, and regulatory compliance needs. Secondary sources included regulatory guidance documents and widely accepted technical standards relevant to sterile compounding and medical device interoperability.

Data triangulation methods were applied to cross-validate themes that emerged during interviews with available technical specifications and vendor materials. Validation steps included follow-up interviews to refine understanding of implementation timelines and service continuity strategies. Where applicable, vendor-provided validation protocols and installation narratives were reviewed to assess the practicalities of commissioning and ongoing maintenance. The methodology emphasizes transparency in source types and applies critical appraisal to reconcile differing perspectives and identify convergent themes.

Stakeholder confidentiality and anonymization protocols were observed for all primary engagements to ensure candid feedback. The resulting analysis focuses on operational and strategic implications rather than proprietary performance claims, making the findings applicable to clinical and procurement audiences seeking practical guidance for system selection and implementation.

A concise conclusion that synthesizes implications for clinical safety, operational resilience, and strategic procurement of robotic IV compounding systems

Robotic IV compounding systems are positioned as transformative tools that enhance medication safety, improve process consistency, and address workforce constraints within pharmacy operations. Their adoption requires a holistic approach that aligns clinical imperatives with procurement strategies and long-term service commitments. Stakeholders benefit most when decisions account for application-specific requirements, differences between integrated and standalone system architectures, and the availability of robust validation and training resources.

Operational resilience depends on selecting vendors with reliable hardware, interoperable software, and proven service frameworks, particularly in the context of supply chain variability and evolving regulatory expectations. Successful implementation hinges on cross-functional planning, staged deployment, and continuous monitoring against safety and performance metrics. By applying disciplined procurement practices and structured change management, healthcare organizations can realize the dual goals of enhancing patient safety and optimizing operational efficiency through targeted automation.

The strategic imperative for organizations is to approach automation adoption with a balance of ambition and pragmatism, ensuring that investments translate into measurable improvements in compounding reliability, staff utilization, and overall quality of care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Robotic IV Compounding System Market, by End User

  • 8.1. Ambulatory Surgical Centers
  • 8.2. Cancer Centers
  • 8.3. Hospitals
    • 8.3.1. Academic Medical Centers
    • 8.3.2. Community Hospitals
  • 8.4. Retail Pharmacies
  • 8.5. Specialty Pharmacies

9. Robotic IV Compounding System Market, by Application

  • 9.1. Analgesia
  • 9.2. Chemotherapy
  • 9.3. Parenteral Nutrition

10. Robotic IV Compounding System Market, by System Type

  • 10.1. Integrated Pharmacy Automation Systems
  • 10.2. Standalone Systems

11. Robotic IV Compounding System Market, by Component

  • 11.1. Hardware
    • 11.1.1. Barcode Scanners
    • 11.1.2. Gravimetric Scales
    • 11.1.3. Robot Arms
    • 11.1.4. Vision Systems
  • 11.2. Services
  • 11.3. Software

12. Robotic IV Compounding System Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Robotic IV Compounding System Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Robotic IV Compounding System Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Robotic IV Compounding System Market

16. China Robotic IV Compounding System Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. AmerisourceBergen Corporation
  • 17.6. ARxIUM Inc.
  • 17.7. Baxter International Inc.
  • 17.8. Becton, Dickinson and Company
  • 17.9. Cerner Corporation
  • 17.10. Fagron Sterile Services
  • 17.11. ForHealth Technologies
  • 17.12. Fresenius Kabi AG
  • 17.13. Integrated Pharmacy Systems, LLC
  • 17.14. Intelligen, Inc.
  • 17.15. Kirby Lester LLC
  • 17.16. KUKA AG
  • 17.17. MedAvail Technologies, Inc.
  • 17.18. Omnicell, Inc.
  • 17.19. QFix GmbH
  • 17.20. ScriptPro LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY CANCER CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY CANCER CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY CANCER CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY ACADEMIC MEDICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY ACADEMIC MEDICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY ACADEMIC MEDICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SPECIALTY PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SPECIALTY PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SPECIALTY PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY ANALGESIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY ANALGESIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY ANALGESIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY CHEMOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY CHEMOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY PARENTERAL NUTRITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY PARENTERAL NUTRITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY INTEGRATED PHARMACY AUTOMATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY INTEGRATED PHARMACY AUTOMATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY INTEGRATED PHARMACY AUTOMATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY STANDALONE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY STANDALONE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY STANDALONE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY BARCODE SCANNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY BARCODE SCANNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY BARCODE SCANNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY GRAVIMETRIC SCALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY GRAVIMETRIC SCALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY GRAVIMETRIC SCALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY ROBOT ARMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY ROBOT ARMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY ROBOT ARMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY VISION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY VISION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY VISION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 130. GCC ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GCC ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. GCC ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 133. GCC ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. GCC ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. GCC ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 136. GCC ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 151. G7 ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. G7 ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. G7 ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 154. G7 ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. G7 ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. G7 ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 157. G7 ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 158. NATO ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. NATO ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. NATO ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 161. NATO ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. NATO ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. NATO ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 164. NATO ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. UNITED STATES ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. UNITED STATES ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 174. CHINA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. CHINA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. CHINA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. CHINA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 179. CHINA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)